BACKGROUND: The 2013-2016 Ebola epidemic in West Africa resulted in accelerated development of rapid diagnostic tests for emergency outbreak preparedness. We describe the development and evaluation of the Idylla™ prototype Ebola virus test, a fully automated sample-to-result molecular diagnostic test for rapid detection of Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). METHODS: The Idylla™ prototype Ebola virus test can simultaneously detect EBOV and SUDV in 200 µL of whole blood. The sample is directly added to a disposable cartridge containing all reagents for sample preparation, RNA extraction, and amplification by reverse-transcription polymerase chain reaction analysis. The performance was evaluated with a variety of sample types, including synthetic constructs and whole blood samples from healthy volunteers spiked with viral RNA, inactivated virus, and infectious virus. RESULTS: The 95% limits of detection for EBOV and SUDV were 465 plaque-forming units (PFU)/mL (1010 copies/mL) and 324 PFU/mL (8204 copies/mL), respectively. In silico and in vitro analyses demonstrated 100% correct reactivity for EBOV and SUDV and no cross-reactivity with relevant pathogens. The diagnostic sensitivity was 97.4% (for EBOV) and 91.7% (for SUDV), the specificity was 100%, and the diagnostic accuracy was 95.9%. CONCLUSIONS: The Idylla™ prototype Ebola virus test is a fast, safe, easy-to-use, and near-patient test that meets the performance criteria to detect EBOV in patients with suspected Ebola.
BACKGROUND: The 2013-2016 Ebola epidemic in West Africa resulted in accelerated development of rapid diagnostic tests for emergency outbreak preparedness. We describe the development and evaluation of the Idylla™ prototype Ebola virus test, a fully automated sample-to-result molecular diagnostic test for rapid detection of Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). METHODS: The Idylla™ prototype Ebola virus test can simultaneously detect EBOV and SUDV in 200 µL of whole blood. The sample is directly added to a disposable cartridge containing all reagents for sample preparation, RNA extraction, and amplification by reverse-transcription polymerase chain reaction analysis. The performance was evaluated with a variety of sample types, including synthetic constructs and whole blood samples from healthy volunteers spiked with viral RNA, inactivated virus, and infectious virus. RESULTS: The 95% limits of detection for EBOV and SUDV were 465 plaque-forming units (PFU)/mL (1010 copies/mL) and 324 PFU/mL (8204 copies/mL), respectively. In silico and in vitro analyses demonstrated 100% correct reactivity for EBOV and SUDV and no cross-reactivity with relevant pathogens. The diagnostic sensitivity was 97.4% (for EBOV) and 91.7% (for SUDV), the specificity was 100%, and the diagnostic accuracy was 95.9%. CONCLUSIONS: The Idylla™ prototype Ebola virus test is a fast, safe, easy-to-use, and near-patient test that meets the performance criteria to detect EBOV in patients with suspected Ebola.
Authors: R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa Journal: J Clin Microbiol Date: 1990-03 Impact factor: 5.948
Authors: Sophie J Smither; Calli Lear-Rooney; Julia Biggins; Jamie Pettitt; Mark S Lever; Gene G Olinger Journal: J Virol Methods Date: 2013-06-05 Impact factor: 2.014
Authors: E M Leroy; S Baize; C Y Lu; J B McCormick; A J Georges; M C Georges-Courbot; J Lansoud-Soukate; S P Fisher-Hoch Journal: J Med Virol Date: 2000-04 Impact factor: 2.327
Authors: Mara Jana Broadhurst; John Daniel Kelly; Ann Miller; Amanda Semper; Daniel Bailey; Elisabetta Groppelli; Andrew Simpson; Tim Brooks; Susan Hula; Wilfred Nyoni; Alhaji B Sankoh; Santigi Kanu; Alhaji Jalloh; Quy Ton; Nicholas Sarchet; Peter George; Mark D Perkins; Betsy Wonderly; Megan Murray; Nira R Pollock Journal: Lancet Date: 2015-06-25 Impact factor: 79.321
Authors: Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol Journal: J Virol Date: 2004-04 Impact factor: 5.103
Authors: Miles W Carroll; David A Matthews; Julian A Hiscox; Michael J Elmore; Georgios Pollakis; Andrew Rambaut; Roger Hewson; Isabel García-Dorival; Joseph Akoi Bore; Raymond Koundouno; Saïd Abdellati; Babak Afrough; John Aiyepada; Patience Akhilomen; Danny Asogun; Barry Atkinson; Marlis Badusche; Amadou Bah; Simon Bate; Jan Baumann; Dirk Becker; Beate Becker-Ziaja; Anne Bocquin; Benny Borremans; Andrew Bosworth; Jan Peter Boettcher; Angela Cannas; Fabrizio Carletti; Concetta Castilletti; Simon Clark; Francesca Colavita; Sandra Diederich; Adomeh Donatus; Sophie Duraffour; Deborah Ehichioya; Heinz Ellerbrok; Maria Dolores Fernandez-Garcia; Alexandra Fizet; Erna Fleischmann; Sophie Gryseels; Antje Hermelink; Julia Hinzmann; Ute Hopf-Guevara; Yemisi Ighodalo; Lisa Jameson; Anne Kelterbaum; Zoltan Kis; Stefan Kloth; Claudia Kohl; Miša Korva; Annette Kraus; Eeva Kuisma; Andreas Kurth; Britta Liedigk; Christopher H Logue; Anja Lüdtke; Piet Maes; James McCowen; Stéphane Mély; Marc Mertens; Silvia Meschi; Benjamin Meyer; Janine Michel; Peter Molkenthin; César Muñoz-Fontela; Doreen Muth; Edmund N C Newman; Didier Ngabo; Lisa Oestereich; Jennifer Okosun; Thomas Olokor; Racheal Omiunu; Emmanuel Omomoh; Elisa Pallasch; Bernadett Pályi; Jasmine Portmann; Thomas Pottage; Catherine Pratt; Simone Priesnitz; Serena Quartu; Julie Rappe; Johanna Repits; Martin Richter; Martin Rudolf; Andreas Sachse; Kristina Maria Schmidt; Gordian Schudt; Thomas Strecker; Ruth Thom; Stephen Thomas; Ekaete Tobin; Howard Tolley; Jochen Trautner; Tine Vermoesen; Inês Vitoriano; Matthias Wagner; Svenja Wolff; Constanze Yue; Maria Rosaria Capobianchi; Birte Kretschmer; Yper Hall; John G Kenny; Natasha Y Rickett; Gytis Dudas; Cordelia E M Coltart; Romy Kerber; Damien Steer; Callum Wright; Francis Senyah; Sakoba Keita; Patrick Drury; Boubacar Diallo; Hilde de Clerck; Michel Van Herp; Armand Sprecher; Alexis Traore; Mandiou Diakite; Mandy Kader Konde; Lamine Koivogui; N'Faly Magassouba; Tatjana Avšič-Županc; Andreas Nitsche; Marc Strasser; Giuseppe Ippolito; Stephan Becker; Kilian Stoecker; Martin Gabriel; Hervé Raoul; Antonino Di Caro; Roman Wölfel; Pierre Formenty; Stephan Günther Journal: Nature Date: 2015-06-17 Impact factor: 49.962
Authors: Jason W Benzine; Kerry M Brown; Krystle N Agans; Ronald Godiska; Chad E Mire; Krishne Gowda; Brandon Converse; Thomas W Geisbert; David A Mead; Yogesh Chander Journal: J Infect Dis Date: 2016-09-16 Impact factor: 5.226
Authors: M S Cherif; N Koonrungsesomboon; M P Diallo; E Le Gall; D Kassé; F Cherif; A Koné; M Diakité; F Camara; N Magassouba Journal: Eur J Clin Microbiol Infect Dis Date: 2016-11-25 Impact factor: 3.267